Using time-weighted average change from baseline of SARS-CoV-2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID-19

By sjmartinez • October 18, 2022

Kumbhakar R, Neradilek M, Barnabas RV, Stewart J, Stankiewicz Karita HC, Landovitz RJ, Kissinger PJ, Jerome KR, Paasche-Orlow MK, Bershteyn A, Chu HY, Neuzil KM, Greninger AL, Luk A, Wald A, Brown ER, Johnston C. Using time-weighted average change from baseline of SARS-CoV-2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID-19. J Med Virol. 2022 Dec;94(12):6091-6096. doi: 10.1002/jmv.28054. Epub 2022 Aug 23. PMID: 35940869; PMCID: PMC9538473.

Tags: CARE Unit, covid-19, early treatment, hydroxychloroquine, Infectious Diseases, PEP, Publications, SARS-CoV-2

Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis

Landovitz RJ, Delany-Moretlwe S, Fogel JM, Eshleman SH, Marzinke MA, Piwowar-Manning E, Richardson P, Halvas EK, Mellors JW, Persaud D, Kofron R, McCauley M, Rose[...]

Arrhythmogenic effects of acute electronic cigarette compared to tobacco cigarette smoking in people living with HIV

Ruedisueli I, Shi K, Lopez S, Gornbein J, Middlekauff HR. Arrhythmogenic effects of acute electronic cigarette compared to tobacco cigarette smoking in people living with[...]

Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis

Fogel JM, Piwowar-Manning E, Moser A, Hill T, Ahmed S, Cummings V, Mostafa HH, Wang Z, Jennings A, Gallardo-Cartagena JA, Figueroa MI, St Clair M,[...]